| FOR IMMEDIATE RELEASE – June 09, 2022 – Camarillo, California, Green Pharmaceuticals Inc is voluntarily recalling lot 2373/21222 of SnoreStop NasoSpray, packaged in 0.3 FL OZ (9ml) bottles to the consumer level. FDA testing found product to contain microbial contamination identified as Providencia rettgeri. This microorganism is rarely associated with human illness; however, in immunocompromised patients, the use of the recalled product could potentially result in severe or life-threatening adverse events such as bacteremia/sepsis, pneumonia, invasive fungal rhinosinusitis, or disseminated fungal infection. In non-immunocompromised patients, the use of the recalled product may result in infectious complications that are expected to be less severe and more readily responsive to treatment. To date, Green Pharmaceuticals Inc has not received any reports of adverse events related to this recalled lot. The product is used as a nasal spray to temporarily help stop or reduce symptoms of non-apneic snoring and is packaged in one single unit plastic bottle with a nasal pump as a delivery system. | | | |
No comments:
Post a Comment